Concepedia

Bruce D. Cohen

BD

13

Publications

1.2K

Citations

12

H-Index

1988

Active since

Affiliations

National Cancer Institute(Current)

Pfizer (United States)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Germany)

Bruce D. Cohen is an author at National Cancer Institute specializing in medicine, cell biology, and cell signaling.

Top concepts

Publications per year

1988–2013

13

Publications

13

Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871

Bruce D. Cohen, Deborah A. Baker, Catherine Soderstrom et al. · Clinical Cancer Research · 2005 · 361 citations · Full text

Identification and characterization of the neurofibromatosis type 1 protein product.

Jeffrey E. DeClue, Bruce D. Cohen, Douglas R. Lowy · Proceedings of the National Academy of Sciences · 1991 · 212 citations · Full text

, , +20

Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451

W. Gregory Roberts, Pamela Whalen, Erik Soderstrom et al. · Cancer Research · 2005 · 135 citations · Full text

The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells

Bruce D. Cohen, Peter A. Kiener, Janell M. Green et al. · Journal of Biological Chemistry · 1996 · 125 citations · Full text

PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy

Jitesh P. Jani, Joel T. Arcari, Vincent Bernardo et al. · Molecular Cancer Therapeutics · 2010 · 87 citations

, , +15

Rows per page

1–5 of 13